Cargando…

Infected Cell Protein (ICP)47 Enhances Herpes Simplex Virus Neurovirulence by Blocking the CD8(+) T Cell Response

The herpes simplex virus (HSV) infected cell protein (ICP)47 blocks CD8(+) T cell recognition of infected cells by inhibiting the transporter associated with antigen presentation (TAP). In vivo, HSV-1 replicates in two distinct tissues: in epithelial mucosa or epidermis, where the virus enters senso...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldsmith, Kim, Chen, Wei, Johnson, David C., Hendricks, Robert L.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1998
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212130/
https://www.ncbi.nlm.nih.gov/pubmed/9449714
Descripción
Sumario:The herpes simplex virus (HSV) infected cell protein (ICP)47 blocks CD8(+) T cell recognition of infected cells by inhibiting the transporter associated with antigen presentation (TAP). In vivo, HSV-1 replicates in two distinct tissues: in epithelial mucosa or epidermis, where the virus enters sensory neurons; and in the peripheral and central nervous system, where acute and subsequently latent infections occur. Here, we show that an HSV-1 ICP47(−) mutant is less neurovirulent than wild-type HSV-1 in mice, but replicates normally in epithelial tissues. The reduced neurovirulence of the ICP47(−) mutant was due to a protective CD8(+) T cell response. When compared with wild-type virus, the ICP47(−) mutant expressed reduced neurovirulence in immunologically normal mice, and T cell–deficient nude mice after reconstitution with CD8(+) T cells. However, the ICP47(−) mutant exhibited normal neurovirulence in mice that were acutely depleted of CD8(+) T cells, and in nude mice that were not reconstituted, or were reconstituted with CD4(+) T cells. In contrast, CD8(+) T cell depletion did not increase the neurovirulence of an unrelated, attenuated HSV-1 glycoprotein (g)E(−) mutant. ICP47 is the first viral protein shown to influence neurovirulence by inhibiting CD8(+) T cell protection.